MolNFT v1 · #87358 · protein
APO GLXR
4BYY · Transcriptional regulator, CRP/FNR family: “APO GLXR”. X-ray diffraction, 1 ligand (PO4), 5 pockets (best druggability 0.78). MolNFT v1 #87358 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 4BYY
- Type
- protein
- Length
- 428 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Transcriptional regulator, CRP/FNR family
- UniProt
- Q79VI7
- Ligands
- PO4
- Pockets
- 5 · best druggability 0.78
Structure
x-ray diffraction · 2 distinct chains · 46% helix, 25% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Transcriptional regulator, CRP/FNR family | protein | 226 | 46% helix, 26% strand | Q79VI7 |
| B | Transcriptional regulator, CRP/FNR family | protein | 202 | 46% helix, 24% strand | Q79VI7 |
Ligands and binding sites
- PO4 · Phosphate ion · ion · 2 copies · chains A, B
- GOL · Glycerol · additive · 2 copies · chains A, B
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 693 | 0.78 | 0.83 | 59 | PO4 |
| 2 | 1086 | 0.74 | 0.77 | 94 | PO4 |
| 3 | 84 | 0.40 | 0.78 | 17 | empty |
| 4 | 56 | 0.35 | 0.79 | 16 | empty |
| 5 | 59 | 0.29 | 0.74 | 19 | empty |
Interfaces
1 interface between chains.
- A–B · 1538 Ų buried · 8 hydrogen bonds · protein-protein
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q79VI7
- Elsewhere: RCSB PDB 4BYY · PDBe 4BYY · UniProt Q79VI7
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.